J2253 HCPCS Level II code: Injection, midazolam (seizalam), 1 mg
J2253 is the HCPCS code for “Injection, midazolam (seizalam), 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2253Injection, midazolam (seizalam), 1 mg
Short description: Inj midazolam (seizalam)
HCPCS · United States
Medicare details
The indicators CMS publishes with J2253 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Oct 1, 2024
Where J2253 sits
- 1J codesDrugs administered other than orally
- 2Active code J2253Injection, midazolam (seizalam), 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2253 mean?
J2253 is the HCPCS code for “Injection, midazolam (seizalam), 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2253?
CMS lists J2253’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2253
All J codesJ2247Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mgJ2248Injection, micafungin sodium, 1 mgJ2249Injection, remimazolam, 1 mgJ2250Injection, midazolam hydrochloride, per 1 mgJ2251Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mgJ2252Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mgJ2260Injection, milrinone lactate, 5 mgJ2265Injection, minocycline hydrochloride, 1 mgJ2267Injection, mirikizumab-mrkz, 1 mgJ2270Injection, morphine sulfate, up to 10 mgJ2271Injection, morphine sulfate, 100mgJ2272Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg